Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage

被引：0
|
作者：
Santoro, A
Santoro, M
Maiorino, L
Forestieri, V
Forestieri, P
机构：
[1] San Gennaro Hosp, OU Med Oncol, Naples, Italy
[2] Univ Naples Federico II, Chair Oncol Surg, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
647
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [41] Gemcitabine in the treatment of patients with advanced transitional cell carcinoma: A phase II study
    Kuzel, T
    Stadler, W
    Raghavan, D
    Levine, E
    Vogelzang, N
    Roth, B
    Dorr, FA
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1152 - 1152
  • [42] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Eroglu, Zeynep
    Fruehauf, John P.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 263 - 267
  • [43] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Zeynep Eroglu
    John P. Fruehauf
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 263 - 267
  • [44] Quality of life during gemcitabine plus cisplatin or gemcitabine plus carboplatin for urothelial carcinoma
    Hatakeyama, S.
    Yoneyama, T.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] A PHASE-II STUDY OF CARBOPLATIN IN METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    不详
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (04): : 375 - 377
  • [46] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    [J]. ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [47] Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma - A phase II trial using a triplet combination
    Leong, SS
    Wee, J
    Tay, MH
    Toh, CK
    Tan, SB
    Thng, CH
    Foo, KF
    Lim, WT
    Tan, T
    Tan, EH
    [J]. CANCER, 2005, 103 (03) : 569 - 575
  • [48] Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma - A phase I/II trial of gemcitabine, paclitaxel, and methotrexate
    Lara, PN
    Meyers, FJ
    Law, LY
    Dawson, NA
    Houston, J
    Lauder, I
    Edelman, MJ
    [J]. CANCER, 2004, 100 (01) : 82 - 88
  • [49] Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma
    Tsao, Che-Kai
    Agarwal, Neeraj
    Apolo, Andrea Borghese
    Lee, Karen M.
    Godbold, James H.
    Oh, William K.
    Galsky, Matt D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [50] Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract -: An alternative therapy
    Nogué-Aliguer, M
    Carles, J
    Arrivi, A
    Juan, O
    Alonso, L
    Font, A
    Mellado, B
    Garrido, P
    Sáenz, A
    [J]. CANCER, 2003, 97 (09) : 2180 - 2186
12345